Fig. 6
From: A novel circular RNA circENTPD7 contributes to glioblastoma progression by targeting ROS1
knockdown circENTPD7 inhibited tumor growth in vivo. a Representative picture showing excised tumors from circENTPD7 knockdown group (sh-circENTPD7) were much smaller than the negative control group. b Tumor growth curves of the excised tumors were shown. c Tumor weight of the excised tumors were shown. d Expression of miR-101-3p was much higher in sh-circENTPD7 group than in the control group measured by RT-qPCR. e Expression of ROS1 was much lower in sh-circENTPD7 group than in the control group measured by western blot. Representative images of western blot were shown. Data are presented as mean ± SD, Student’s t test, *P < 0.05, **P < 0.01